Tag: healthbeacon

HealthBeacon launches HB Smart Pills Solution

HealthBeacon plc (“HealthBeacon”), the leading digital therapeutics company for injectable medications, has extended its platform to manage complex and critical pill regimens with the launch of its new HB Smart Pills Management System (“HB Smart Pills”).

 The announcement will be made at HealthBeacon’s inaugural Vision Event in Boston later today where CEO Jim Joyce will share the Company’s vision from 2022 to 2024, with an interactive product showcase of the Company’s medication adherence technology following talks by global industry leaders and patient advocates on healthcare innovation using digital health technology.

The launch follows the Company’s recent addition of the integrated HB Smart Scale and the partnership with the American Pharmacists Association Foundation.

The HB Smart Pills solution is an elegant device designed to fit into a patient’s home managing up to nine oral medications and integrates seamlessly with the Company’s existing technology platform. The innovative HB Smart Pills solution notifies the patient when prescription refills are required and records visual images of pill containers to ascertain medication adherence.

Adherence to pill regimes is a significant challenge for people with chronic illnesses managing multiple critical medications at different intervals, with up to 60% of patients globally failing to take their medications as prescribed. The U.S. oral solid dosage pharmaceutical market was valued at $214.1 billion in 2021 and is expected to exceed $420.3 billion by 2032.

Expanding the Company’s product offering to now include Pill Management enables HealthBeaconto continue to roll out its technology and services through pharmaceutical companies, specialty pharmacy and governments, deepening its existing relationships and increasing its customer base.

 HB Smart Pills will be available through the company’s existing distribution channels in 2023.  To learn more contact HBSmartPills@HealthBeacon.com 

 

Commenting, HealthBeacon CEO and co-founder, Jim Joyce, said: “Today’s launch of the HB Smart Pills at our inaugural Vision Event is a significant milestone for the Company on its path to becoming the world’s leading digital therapeutics platform for patients managing medications in the home. Broadening our product offering and connecting HealthBeacon members to better health with digitally enabled solutions is an important step on this journey. The recent new product announcements of the HB Smart Pills and integrated Smart Scale build on the significant momentum in the business as leading pharma companies and health systems adopt our technology.”

 

 

 

HealthBeacon launches its integrated Smart Scale

Healthbeacon plc, the leading digital therapeutics company that develops products for managing injectable medications for patients in the home, has today announced the launch of its new Smart Scale, an integrated solution that forms part of its Injection Care Management System (ICMS).

The HealthBeacon Smart Scale enables patients to add weight monitoring to its ICMS, as the connected weight scale tracks weight progression, providing clinical teams with insights on specific medication outcomes.

There are currently nine million patients in the U.S. that self-administer injectable medications in the home, and many require their weight to be carefully managed and monitored. HealthBeacon’s integrated Smart Scale will sync seamlessly with its ICMS, helping patients improve adherence to therapies and providing healthcare practitioners with access to important clinical data.

HealthBeacon provides each member of its injection care management system with a Smart Sharps Bin, a companion app, a more sustainable waste management service, and now, the integrated Smart Scale. This enhances a system that already improves the likelihood of success on therapy by increasing adherence by as much as 26% and persistence by 19% according to peer reviewed research.

It is expected that the HealthBeacon Smart Scale will become available to HealthBeacon patients this autumn.

Commenting, HealthBeacon CEO and co-founder, Jim Joyce, said: “The launch of the HB Smart Scale is an important step as we strive to improve injection adherence globally. Weight management is an important factor in the health of many patients that are required to self-administer injectable medications at home. This product integrates seamlessly into our technology which patients are already using, meaning this addition can improve their health with no added level of complexity.”

The announcement of the launch of HealthBeacon’s Smart Scale was made at the annual MAGIC conference in Chicago, the largest patient conference for children with growth disorders. The monitoring of weight progression is of particular importance to children suffering from growth disorders.

Commenting further, Mr Joyce said: “We know how difficult it is for families that must administer injections to their children at home. For children on growth hormones, it can be difficult to both manage injections and monitor growth progress. HealthBeacon’s Smart Scale will support affected families by enabling parents to track their child’s growth along with monitoring injection adherence. It also benefits children as they become teenagers and can administer medication themselves, providing them with a level of independence while enabling their parents to continue to monitor their adherence and track their growth.”